Generation Bio

Acquired

Generation Bio is a biotech company in Cambridge, United States, founded in 2016. It has raised $235.0M across 3 rounds, most recently a $110.0M Series C in January 2020.

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$235.0M
Last Round
$110.0M Series CJan 2020
Rounds
3
Type
Public
Acquisition Date
Dec 2025

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Generation Bio is a biotechnology company that developed a T cell-selective cell-targeted lipid nanoparticle (ctLNP) platform to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company went public and subsequently underwent a phased restructuring before being acquired by XOMA Royalty in February 2026. Its ctLNP delivery system achieved the first-ever selective delivery of siRNA to T cells in non-human primates.

Summary

It lists 51–200 employees. It has raised $235.0M in total across 3 rounds, most recently a $110.0M Series C round in Jan 2020. Investors include Atlas Venture, T. Rowe Price and Farallon Capital.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionAcquisition by XOMADec 2025

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Generation Bio on Indexed.vc
<a href="https://indexed.vc/companies/generation-bio"><img src="https://indexed.vc/api/badge/company/generation-bio" alt="Generation Bio on Indexed.vc" width="260" height="76" /></a>